Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
44.36 USD | +0.70% | -0.81% | +49.97% |
May. 03 | Sector Update: Health Care Stocks Mixed in Afternoon Trading | MT |
May. 03 | Tandem Diabetes Care Shares Rise After Q1 Net Loss Shrinks, Sales Rise; Q2, 2024 Sales Guidance Set | MT |
Evolution of the average Target Price on Tandem Diabetes Care, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Tandem Diabetes Care, Inc.
UBS | |
Wells Fargo Securities | |
Leerink Partners | |
Stifel Nicolaus | |
Citigroup | |
TD Cowen | |
BofA Securities | |
Jefferies & Co. | |
Baird | |
Barclays | |
Craig-Hallum | |
Raymond James | |
Cowen | |
Piper Sandler | |
Wolfe Research | |
Lake Street | |
Oppenheimer | |
SVB Leerink | |
Berenberg Bank |
EPS Revisions
- Stock Market
- Equities
- TNDM Stock
- Consensus Tandem Diabetes Care, Inc.